Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity

Journal of Clinical Oncology

Volumn 26, Issue 11, 2008, Pages 1858-1864

  Hoppe, Bradford S ^a   Moskowitz, Craig H ^a   Filippa, Daniel A ^a   Moskowitz, Chaya S ^a   Kewalramani, Tarun ^a   Zelenetz, Andrew D ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; ADOLESCENT; AGED; AUTOTRANSPLANTATION; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ILEUS; LUNG DISEASE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION INJURY; RADIOTHERAPY; SALVAGE THERAPY; SECOND CANCER; SKIN TUMOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ILEUS; LUNG DISEASES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; SKIN NEOPLASMS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 42949157851     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.4773     Document Type: Article

References (36)

1. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
2. Fisher RI, Gaynor ER, Dahlberg S, et al: A phase III comparison of CHOP vs m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study. Ann Oncol 5:91-95, 1994 (suppl)
3. Philip T, Chauvin F, Armitage J, et al: Parma international protocol: Pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 77:1587-1592, 1991
4. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
5. Takvorian T, Canellos GP, Ritz J, et al: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316:1499-1505, 1987
6. Nademanee A, Molina A, Dagis A, et al: Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma. Clin Lymphoma 1:46-54, 2000
7. Wendland MM, Smith DC, Boucher KM, et al: The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant. Am J Clin Oncol 30:156-162, 2007
8. Mundt AJ, Williams SF, Hallahan D: High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy. Int J Radiat Oncol Biol Phys 39:617-625, 1997
9. Emmanouilides C, Asuncion DJ, Wolf C, et al: Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplant 32:863-867, 2003
10. Friedberg JW, Neuberg D, Monson E, et al: The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 7:446-453, 2001
11. Tsang RW, Gospodarowicz MK, Sutcliffe SB, et al: Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease: PMH Lymphoma Group, and the Toronto Autologous BMT Group. Eur J Cancer 35:73-78, 1999
12. Jules-Elysee K, Stover DE, Yahalom J, et al: Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 146:485-491, 1992
13. Rodriguez J, Caballero MD, Gutierrez A, et al: Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience. Ann Oncol 15:1504-1509, 2004
14. Yahalom J, Mauch P: The involved field is back: Issues in delineating the radiation field in Hodgkin's disease. Ann Oncol 13:79-83, 2002 (suppl)
15. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
16. Fenske TS, Kahl BS, Eickhoff J, et al: Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma. Leuk Lymphoma 46:1441-1448, 2005
17. Geisler CH, Hansen MM, Andersen NS, et al: BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre - Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment. Eur J Haematol 61:173-182, 1998
18. Schmitz N, Linch DC, Dreger P, et al: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353-357, 1996
19. Puig N, de la Rubia J, Remigia MJ, et al: Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk Lymphoma 47:1488-1494, 2006
20. Goodman KA, Toner S, Hunt M, et al: Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 62:198-206, 2005
21. Rapoport AP, Lifton R, Constine LS, et al: Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): Long-term follow-up and analysis of prognostic factors. Bone Marrow Transplant 19:883-890, 1997
22. Toren A, Nagler R, Nagler A: Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities. Med Oncol 15:113-118, 1998
23. Gulati S, Yahalom J, Acaba L, et al: Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. J Clin Oncol 10:936-941, 1992
24. Vose JM, Anderson JR, Kessinger A, et al: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846-1851, 1993
25. Rapoport AP, Guo C, Badros A, et al: Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma. Bone Marrow Transplant 34:883-890, 2004
26. Kalaycio M, Rybicki L, Pohlman B, et al: Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia. J Clin Oncol 24:3604-3610, 2006
27. Stiff PJ, Dahlberg S, Forman SJ, et al: Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens - A Southwest Oncology Group trial. J Clin Oncol 16:48-55, 1998
28. Bertz H, Zeiser R, Lange W, et al: Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index. Ann Oncol 15:1419-1424, 2004
29. Caballero MD, Perez-Simon JA, Iriondo A, et al: High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 14:140-151, 2003
30. Kahn ST, Flowers CR, Lechowicz MJ, et al: Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: Optimizing involved-field radiotherapy in transplant patients. Cancer J 11:425-431, 2005
31. Lancet JE, Rapoport AP, Brasacchio R, et al: Autotransplantation for relapsed or refractory Hodgkin's disease: Long-term follow-up and analysis of prognostic factors. Bone Marrow Transplant 22:265-271, 1998
32. Mundt AJ, Sibley G, Williams S, et al: Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys 33:261-270, 1995
33. Vose JM, Zhang MJ, Rowlings PA, et al: Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 19:406-413, 2001
34. Wadhwa PD, Fu P, Koc ON, et al: High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality. Biol Blood Marrow Transplant 11:13-22, 2005
35. Wendland MM, Asch JD, Pulsipher MA, et al: The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease. Am J Clin Oncol 29:189-195, 2006
36. Poen JC, Hoppe RT, Horning SJ: High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival. Int J Radiat Oncol Biol Phys 36:3-12, 1996